Endonovo Financial Statements From 2010 to 2025
| ENDV Stock | USD 0.0003 0.0001 25.00% |
Check Endonovo Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Endonovo Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Endonovo financial statements analysis is a perfect complement when working with Endonovo Therapeutics Valuation or Volatility modules.
Endonovo |
Endonovo Therapeutics Company Shares Outstanding Analysis
Endonovo Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Endonovo Therapeutics Shares Outstanding | 194.33 M |
Most of Endonovo Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Endonovo Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Endonovo Therapeutics has 194.33 M of shares currently outstending. This is 7.64% higher than that of the Biotechnology sector and 81.86% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 66.02% higher than that of the company.
Endonovo Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Endonovo Therapeutics's current stock value. Our valuation model uses many indicators to compare Endonovo Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Endonovo Therapeutics competition to find correlations between indicators driving Endonovo Therapeutics's intrinsic value. More Info.Endonovo Therapeutics is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Endonovo Therapeutics' earnings, one of the primary drivers of an investment's value.About Endonovo Therapeutics Financial Statements
Endonovo Therapeutics investors use historical fundamental indicators, such as Endonovo Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Endonovo Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California. Endonovo Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Endonovo Pink Sheet Analysis
When running Endonovo Therapeutics' price analysis, check to measure Endonovo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endonovo Therapeutics is operating at the current time. Most of Endonovo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Endonovo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endonovo Therapeutics' price. Additionally, you may evaluate how the addition of Endonovo Therapeutics to your portfolios can decrease your overall portfolio volatility.